BSE - Delayed Quote INR

Deccan Health Care Ltd (DECCAN.BO)

18.20
+0.29
+(1.62%)
At close: May 9 at 3:28:04 PM GMT+5:30
Loading Chart for DECCAN.BO
  • Previous Close 17.91
  • Open 17.55
  • Bid 18.20 x --
  • Ask 18.21 x --
  • Day's Range 17.50 - 18.49
  • 52 Week Range 16.00 - 31.60
  • Volume 4,615
  • Avg. Volume 60,669
  • Market Cap (intraday) 450.435M
  • Beta (5Y Monthly) -0.22
  • PE Ratio (TTM) 41.36
  • EPS (TTM) 0.44
  • Earnings Date May 27, 2025 - May 31, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Deccan Health Care Limited, a nutraceutical company provides nutritional, personal care, and food-based solutions. It produces and distributes soft gelatin capsules, food pills, vitamin supplements, and nutritional meals. The company also provides its products in the form of creams, liquids, ointments, powders, pastes, special dosages, tablets, hard starch and gel capsules, and soft starch capsules. Deccan Health Care Limited was incorporated in 1996 and is based in Hyderabad, India.

www.deccanhealthcare.co.in

57

Full Time Employees

March 31

Fiscal Year Ends

Recent News: DECCAN.BO

View More

Performance Overview: DECCAN.BO

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

DECCAN.BO
38.37%
S&P BSE SENSEX (^BSESN)
1.68%

1-Year Return

DECCAN.BO
38.72%
S&P BSE SENSEX (^BSESN)
9.74%

3-Year Return

DECCAN.BO
38.72%
S&P BSE SENSEX (^BSESN)
45.87%

5-Year Return

DECCAN.BO
38.72%
S&P BSE SENSEX (^BSESN)
151.10%

Compare To: DECCAN.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DECCAN.BO

View More

Valuation Measures

Annual
As of 5/9/2025
  • Market Cap

    446.72M

  • Enterprise Value

    431.43M

  • Trailing P/E

    41.02

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.63

  • Price/Book (mrq)

    0.45

  • Enterprise Value/Revenue

    0.61

  • Enterprise Value/EBITDA

    13.46

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.65%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    702.79M

  • Net Income Avi to Common (ttm)

    11.63M

  • Diluted EPS (ttm)

    0.44

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    19.55M

  • Total Debt/Equity (mrq)

    1.28%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: DECCAN.BO

View More

Company Insights: DECCAN.BO

Research Reports: DECCAN.BO

View More

People Also Watch